Skip navigation
Acute Pain | Chronic Pain | General

Spinal cord stimulation for complex regional pain syndrome

 

Clinical bottom line

There is limited evidence of long-term benefit from a single randomised trials and a number of case series.


Reference

RS Taylor et al. Spinal cord stimulation for complex regional pain syndrome: a systematic review of the clinical and cost-effectiveness literature and assessment of prognostic factors. European Journal of Pain 2006 10: 91-101.

Systematic review

Results

The randomised trial showed some benefit, with a reduction in pain of 2.4 units (presumably out of 10 on a VAS scale) at six months and 2.7 at 12 months.

The 25 case series were judged to be of generally poor quality, and were small. On average 67% achieved at least 50% pain reduction.

Cost effectiveness was calculated on the basis of the RCT, with a cost per quality-adjusted life year of Euro22,600.

Comment

Little in the way of evidence here, but such as it is implies that spinal cord stimulation can be beneficial in a difficult medical condition.